insights_auto
Why is ARX down २.९७%?
Dive Deeperchevron_right
ARX:ASX
Aroa Biosurgery Ltd
A$ ०.४९
arrow_downward
-२.९७%(-०.०१५) 1D
नोभेम्बर १९, १६:१०:०३ GMT+११ · AUD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARX...
Open
A$ ०.४९
High
A$ ०.५१
Low
A$ ०.४९
Mkt. cap
१६.३७ करोड
Avg. vol.
२.५९ लाख
Volume
२.४६ लाख
P/E ratio
४६.६७
52-wk high
A$ ०.७८
52-wk low
A$ ०.४६
EPS
A$ ०.०१
Shares outstanding
३४.५९ करोड
No. of employees
२६१
Open
A$ ०.४९
High
A$ ०.५१
Low
A$ ०.४९
Mkt. cap
१६.३७ करोड
Avg. vol.
२.५९ लाख
Volume
२.४६ लाख
P/E ratio
४६.६७
52-wk high
A$ ०.७८
52-wk low
A$ ०.४६
EPS
A$ ०.०१
Shares outstanding
३४.५९ करोड
No. of employees
२६१
News stories
From web sources and news partners
24/7 Wall St.
·
२१ मिनेट पहिले
4 S&P 500 Dividend Stocks Paying Shareholders More Than Their Free Cash Flow
Barron's
·
५२ मिनेट पहिले
Sell the S&P 500 Because the AI Bubble Is About to Burst, Analyst Says. Buy This Instead.
BigGo Finance
·
२ घण्टा पहिले
UBS 2027 Outlook: S&P 500 Base Case at 8,200; AI Capex Stall Could Drag It to 5,500
JournalArta
·
४६ मिनेट पहिले
Stock Market Today: Nasdaq and S&P 500 Futures Rise Ahead of Anthropic Debut
Profile
Aroa Biosurgery Limited is a regenerative medicine company that develops, manufactures and distributes products for wound healing and soft tissue reconstruction. Aroa Biosurgery is headquartered in Auckland, New Zealand with a US office in San Diego, CA, and is listed on the Australian Securities Exchange.
The company, originally known as Mesynthes Limited, was founded in 2008 by Veterinarian Surgeon Dr Brian Ward. The company develops and commercializes products based on its proprietary ovine forestomach matrix technology platform with products in wound healing as well as plastics and reconstructive surgery and repair of hernia. Wikipedia
About Aroa Biosurgery Ltd